- Home
- GCTK vs VTAK Comparison
GCTK vs VTAK Comparison
Compare GCTK & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- VTAK
- Stock Information
- Founded
- GCTK 2001
- VTAK 2002
- Country
- GCTK United States
- VTAK United States
- Employees
- GCTK N/A
- VTAK N/A
- Industry
- GCTK Medical/Dental Instruments
- VTAK Medical/Dental Instruments
- Sector
- GCTK Health Care
- VTAK Health Care
- Exchange
- GCTK Nasdaq
- VTAK Nasdaq
- Market Cap
- GCTK 3.3M
- VTAK 3.1M
- IPO Year
- GCTK N/A
- VTAK 2018
- Fundamental
- Price
- GCTK $7.15
- VTAK $2.56
- Analyst Decision
- GCTK
- VTAK
- Analyst Count
- GCTK 0
- VTAK 0
- Target Price
- GCTK N/A
- VTAK N/A
- AVG Volume (30 Days)
- GCTK 3.7M
- VTAK 82.5K
- Earning Date
- GCTK 11-13-2025
- VTAK 11-12-2025
- Dividend Yield
- GCTK N/A
- VTAK N/A
- EPS Growth
- GCTK N/A
- VTAK N/A
- EPS
- GCTK N/A
- VTAK N/A
- Revenue
- GCTK N/A
- VTAK $600,000.00
- Revenue This Year
- GCTK N/A
- VTAK $822.86
- Revenue Next Year
- GCTK N/A
- VTAK $168.42
- P/E Ratio
- GCTK N/A
- VTAK N/A
- Revenue Growth
- GCTK N/A
- VTAK 37.62
- 52 Week Low
- GCTK $4.22
- VTAK $2.20
- 52 Week High
- GCTK $2,928.00
- VTAK $33.06
- Technical
- Relative Strength Index (RSI)
- GCTK 56.95
- VTAK 46.95
- Support Level
- GCTK $6.18
- VTAK $2.53
- Resistance Level
- GCTK $6.66
- VTAK $2.65
- Average True Range (ATR)
- GCTK 0.59
- VTAK 0.16
- MACD
- GCTK 0.06
- VTAK 0.05
- Stochastic Oscillator
- GCTK 58.80
- VTAK 59.65
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.